Sterling Capital Management LLC Supernus Pharmaceuticals, Inc. Transaction History
Sterling Capital Management LLC
- $6.45 Trillion
- Q1 2025
A detailed history of Sterling Capital Management LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 12,778 shares of SUPN stock, worth $424,229. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,778
Previous 14,562
12.25%
Holding current value
$424,229
Previous $527 Million
20.53%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding SUPN
# of Institutions
305Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$345 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$205 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$173 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$96.4 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$89.6 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.78B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...